Journal Guides8 min readUpdated Apr 14, 2026

Is Molecules a Good Journal? Impact Factor, Scope, and Fit Guide

Molecules (IF 4.2, MDPI) is a high-volume OA chemistry journal. Honest comparison with RSC Advances, ACS Omega, and ChemistrySelect, plus the MDPI reputation question.

By Senior Researcher, Chemistry

Senior Researcher, Chemistry

Author context

Specializes in manuscript preparation and peer review strategy for chemistry journals, with deep experience evaluating submissions to JACS, Angewandte Chemie, Chemical Reviews, and ACS-family journals.

Journal fit

See whether this paper looks realistic for Molecules.

Run the Free Readiness Scan with Molecules as your target journal and see whether this paper looks like a realistic submission.

Check my manuscript fitAnthropic Privacy Partner. Zero-retention manuscript processing.See sample reportOr compare against 1000+ journals and conferences
Journal context

Molecules at a glance

Key metrics to place the journal before deciding whether it fits your manuscript and career goals.

Full journal profile
Impact factor4.6Clarivate JCR
Acceptance rate~50-60%Overall selectivity
Time to decision~60-90 days medianFirst decision
Open access APC~$2,100 CHFGold OA option

What makes this journal worth targeting

  • IF 4.6 puts Molecules in a visible tier — citations from papers here carry real weight.
  • Scope specificity matters more than impact factor for most manuscript decisions.
  • Acceptance rate of ~~50-60% means fit determines most outcomes.

When to look elsewhere

  • When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
  • If timeline matters: Molecules takes ~~60-90 days median. A faster-turnaround journal may suit a grant or job deadline better.
  • If OA is required: gold OA costs ~$2,100 CHF. Check institutional agreements before submitting.
Quick verdict

How to read Molecules as a target

This page should help you decide whether Molecules belongs on the shortlist, not just whether it sounds impressive.

Question
Quick read
Best for
Molecules published by MDPI is an open-access journal covering chemistry, biochemistry, and molecular.
Editors prioritize
Novel molecular structure or synthesis with demonstrated characterization
Think twice if
Reporting compound synthesis without sufficient characterization data
Typical article types
Research Article, Short Note, Review

Molecules (IF 4.2, MDPI, Q2 Chemistry Multidisciplinary) is a large open-access chemistry journal with an acceptance rate of roughly 35-45% and publication timelines of 5-8 weeks from submission. It publishes across all areas of molecular science: organic, inorganic, analytical, physical, and biochemistry. The journal has been running since 1996, is indexed in Web of Science, Scopus, and PubMed, and is unambiguously legitimate. The real question is not whether it is a real journal but whether it is the right signal for your career and your paper.

The real question researchers are asking is not whether Molecules is a "real" journal. It is whether publishing there carries the right signal for their career and their paper. That answer depends on what alternatives are available and what the paper's actual competitive position is in the chemistry publishing landscape.

Molecules at a glance

Metric
Value
Impact Factor (2024 JCR)
4.2
CiteScore (2024)
7.3
Publisher
MDPI
APC
~$2,700 (gold OA, mandatory)
Acceptance rate
~35-45%
First decision
2-3 weeks
Time to publication
5-8 weeks from submission
Quartile
Q2 Chemistry, Multidisciplinary
Scope
All molecular science: organic, inorganic, analytical, physical, biochemistry

The editorial distinction: solid chemistry in OA format, not a prestige play

Molecules occupies a specific niche in chemistry publishing. It is not trying to compete with JACS or Angewandte Chemie. It is a venue for complete, well-characterized chemistry research that benefits from open-access visibility and fast turnaround. The papers that work best here are those where the chemistry is sound, the characterization is thorough, and the contribution is clear, but the work does not carry the novelty or significance required by the most selective chemistry journals.

This is an honest position. Not every chemistry paper needs to appear in a top-10 journal, and pretending otherwise leads to years of rejection cycling. Molecules serves researchers who have solid, complete work and want it published, indexed, and citable without a 6-12 month editorial process.

The MDPI reputation concern is real but often overstated. Some hiring committees and grant reviewers view MDPI journals skeptically because of the high-volume model. Others evaluate papers on their individual merit regardless of publisher. The practical advice: if your career depends on selectivity signals (tenure track, competitive grants), a traditional publisher journal at a similar IF may carry more weight even if the science is identical. If your priority is fast, indexed, OA publication of solid work, Molecules does that well.

How Molecules compares to realistic alternatives

Feature
Molecules
RSC Advances
ACS Omega
ChemistrySelect
IF (2024)
4.2
3.6
3.7
1.6
APC
~$2,700
~$1,500
~$2,000
~$1,350
Acceptance rate
~35-45%
~35-40%
~40-50%
~40-50%
Publisher
MDPI
RSC
ACS
Wiley
Speed
5-8 weeks
8-12 weeks
8-12 weeks
6-10 weeks
Perception
MDPI skepticism in some circles
Neutral (RSC brand)
Neutral-positive (ACS brand)
Neutral (Wiley brand)
Best for
Broad chemistry, fast OA
Broad chemical sciences, lower APC
Broad chemistry, ACS brand
Budget-friendly OA chemistry

Four comparisons that matter:

Molecules vs. RSC Advances: RSC Advances (IF 3.6) is the RSC's broad-scope OA journal. It has a lower IF and lower APC. The RSC brand carries slightly better perception in some European and Asian research communities. If perception matters and the APC difference is meaningful, RSC Advances is an alternative. If speed and a slightly higher IF matter, Molecules may edge ahead.

Molecules vs. ACS Omega: ACS Omega (IF 3.7) is the ACS broad-scope OA journal. The ACS brand is strong and carries positive perception in most chemistry departments. ACS Omega is slightly less expensive. If the ACS brand matters for your career context, ACS Omega is worth considering even though Molecules has a marginally higher IF.

Molecules vs. ChemistrySelect: ChemistrySelect (IF 1.6, Wiley) is substantially lower in IF and represents a different tier. If the paper is competitive at Molecules or ACS Omega, ChemistrySelect is probably not the right comparison. It enters the picture only for papers that have been rejected from higher-tier OA venues.

Molecules vs. traditional specialty journals: For papers in specific subfields (natural products, medicinal chemistry, analytical methods), a traditional specialty journal at a similar or slightly lower IF (e.g., Natural Product Reports, Bioorganic & Medicinal Chemistry Letters) may carry a stronger selectivity signal even with a longer review process. The trade-off is speed and breadth vs. specialist credibility.

Submit if

  • The chemistry is complete, well-characterized, and reproducible
  • The paper is solid work that does not carry the novelty or significance for the most selective chemistry journals
  • Fast publication and open-access indexing are genuine priorities for your situation
  • The APC (~$2,700) is within budget or covered by institutional agreements
  • The paper is broad enough that Molecules' wide readership is a genuine advantage over a narrow specialist venue

Journal fit

See whether this paper looks realistic for Molecules.

Run the scan with Molecules as the target. Get a manuscript-specific fit signal before you commit.

Check my manuscript fitAnthropic Privacy Partner. Zero-retention manuscript processing.See sample reportOr compare against 1000+ journals and conferences

Think twice if

  • Your career context requires strong selectivity signals (tenure decisions, competitive grant panels that evaluate journal reputation)
  • ACS Omega or RSC Advances would provide similar visibility with a more traditional publisher brand
  • The paper is strong enough for a selective specialist journal that would carry more weight in your subfield
  • The primary reason for choosing Molecules is speed and convenience rather than genuine audience fit
  • The characterization or reproducibility of the work is not yet complete enough for publication anywhere

What strong Molecules papers share

  1. Complete characterization: all new compounds or materials are fully characterized with appropriate analytical data (NMR, HRMS, IR, XRD as applicable)
  2. Clear chemical advance: the paper identifies what is new about the chemistry, not just what was done
  3. Honest scope: the claims match the data without overstatement or speculative applications
  4. Thorough experimental section: procedures are detailed enough for reproduction, including purification methods and yields
  5. Appropriate comparison: new compounds or methods are compared against existing approaches rather than presented in isolation

Frequently asked questions

What is the Molecules impact factor?

The 2024 JCR impact factor is 4.2. Molecules ranks Q2 in Chemistry, Multidisciplinary and is one of the largest open-access chemistry journals by volume. Its IF has been stable around 4-5 for several years.

What is the Molecules acceptance rate?

Approximately 35-45%. This is higher than most traditional publisher journals but lower than the broadest MDPI titles. The acceptance rate reflects a journal that maintains peer review standards while publishing a high volume of papers.

Is Molecules a predatory journal?

No. Molecules is indexed in Web of Science, Scopus, PubMed, and other major databases. It has a legitimate JCR impact factor and has been published since 1996. However, like all MDPI journals, it faces perception concerns in some research communities about its high-volume OA model. The journal is legitimate; the reputational question is about selectivity signal, not predatory status.

How fast does Molecules publish?

Molecules typically provides a first editorial decision within 2-3 weeks and publishes accepted papers within 5-8 weeks of submission. This is substantially faster than most traditional chemistry journals and is a genuine advantage when speed matters.

Bottom line

Molecules is a legitimate, well-indexed OA chemistry journal with an IF of 4.2 and fast turnaround. It is the right venue for solid, complete chemistry work where the priority is fast OA publication rather than selectivity signaling. The fit test: is the chemistry complete and honest, and is the trade-off between speed/accessibility and publisher perception acceptable for your career context?

If you are unsure whether Molecules is the right tier for your manuscript, a Molecules submission readiness check can evaluate the work's competitive position and suggest whether Molecules, ACS Omega, or a specialist journal is the better target.

What Pre-Submission Reviews Reveal About Molecules Submissions

In our pre-submission review work with manuscripts targeting Molecules, three patterns generate the most consistent desk rejections among the papers we analyze.

Incomplete characterization of new compounds or materials. Molecules' editorial guidelines require complete characterization data for all newly reported compounds: NMR (1H and 13C at minimum), HRMS, melting points where applicable, and purity confirmation by HPLC for biologically tested compounds. In our review work, the most common failure at Molecules is manuscripts with incomplete analytical data packages: missing HRMS for key compounds, 13C NMR absent or incomplete, or biological activity reported without purity data. Molecules peer reviewers check characterization data systematically. Papers with analytical gaps are returned for revision or rejected. The characterization must be complete before submission.

Overclaiming significance relative to the data. A persistent pattern: manuscripts that present incremental synthetic work or modest biological activity with language suggesting broader implications than the data support. Molecules accepts solid, complete chemistry that does not need to be field-defining, but the claims must match the evidence. In our analysis, papers that describe a new compound class as "potentially valuable for drug discovery" based on IC50 values from one cell line, or claim "superior activity" based on comparisons with a small subset of existing compounds, receive reviewer feedback about scope and claim calibration. The journal's peer review process is competent and identifies overstatement consistently.

MDPI format non-compliance. Molecules has specific formatting requirements that differ from traditional chemistry journals: manuscript organization, supplementary information structure, graphical abstract format, and data availability statement. In our review work, we observe manuscripts submitted without the required graphical abstract, with supplementary information formatted for a different publisher, or without the mandatory data availability statement. MDPI's editorial office applies formatting checks before peer review, and non-compliant papers are returned for correction before review begins, adding weeks to the timeline.

SciRev author-reported data confirms Molecules' 2-3 week median to first editorial decision and 5-8 week median to publication after acceptance, substantially faster than most traditional chemistry publishers. A Molecules significance framing check can evaluate whether your characterization package and scope framing are ready for Molecules' editorial process.

Before you submit

A Molecules submission readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.

Frequently asked questions

The 2024 JCR impact factor is 4.2. Molecules ranks Q2 in Chemistry, Multidisciplinary and is one of the largest open-access chemistry journals by volume. Its IF has been stable around 4-5 for several years.

Approximately 35-45%. This is higher than most traditional publisher journals but lower than the broadest MDPI titles. The acceptance rate reflects a journal that maintains peer review standards while publishing a high volume of papers.

No. Molecules is indexed in Web of Science, Scopus, PubMed, and other major databases. It has a legitimate JCR impact factor and has been published since 1996. However, like all MDPI journals, it faces perception concerns in some research communities about its high-volume OA model. The journal is legitimate; the reputational question is about selectivity signal, not predatory status.

Molecules typically provides a first editorial decision within 2-3 weeks and publishes accepted papers within 5-8 weeks of submission. This is substantially faster than most traditional chemistry journals and is a genuine advantage when speed matters.

References

Sources

  1. 1. Molecules homepage, MDPI.
  2. 2. Molecules aims and scope, MDPI.
  3. 3. Clarivate Journal Citation Reports (released June 2025).

Final step

See whether this paper fits Molecules.

Run the Free Readiness Scan with Molecules as your target journal and get a manuscript-specific fit signal before you commit.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Internal navigation

Where to go next

Check my manuscript fit